go-v.orgdoi

The Role of Lipid Metabolism in the Progression of Breast Cancer

Tong‐Tong Liu, Meng-Meng Wang · Journal of Cancer · 2026

  • DOI 10.7150/jca.128498
  • Publisher Ivyspring International Publisher
  • Type review
  • Issued 2026

Not cached yet. This record was fetched live for this request and is stored after the lookup. Reopening the page should serve the cached copy.

Journal of Cancer · Ivyspring International Publisher · review · 2026

Abstract

Breast cancer is one of the most prevalent malignancies globally, it is closely associated with lipid metabolism reprogramming. Targeting lipid metabolism pathways has become a promising strategy for breast cancer treatment. Lipid metabolism encompasses the biochemical processes of lipid biosynthesis, catabolism, uptake, and post-synthetic modification. Dysregulation of these processes can promote tumorigenesis and cancer cell metastasis. This review summarizes four major facets of lipid metabolism, including fatty acid (FA) metabolism, cholesterol metabolism, phospholipid (PL) metabolism, and sphingolipid metabolism.

It also discusses the roles of key molecules in these pathways in breast cancer, including FA synthase (FASN), cluster of differentiation 36 (CD36), and acyl-CoA synthetase long-chain family member 4 (ACSL4). These molecules may improve therapeutic responses, overcome drug resistance, and reshape the tumor immune microenvironment by regulating FA synthesis and lipid uptake. Targeting lipid metabolic pathways may provide potential biomarkers for patient stratification and therapeutic guidance, and may also offer new opportunities for cancer treatment.

Open the resolved locator · 10.7150/jca.128498

Metadata licence: OpenAlex metadata (CC0)

Registry
OpenAlex DOI index + API
Fetched
2026-11-19 23:34 UTC
Cache state
not cached yet (bulk-index+openalex)
Locator
https://www.jcancer.org/v17p0898.htm
Metadata licence
OpenAlex metadata (CC0)
Scope
Metadata as returned by the resolver; abstracts are never generated here.